{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:15:06Z","timestamp":1790784906820,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neuromodulationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromodulation: Technology at the Neural Interface"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.neurom.2022.04.045","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:04:24Z","timestamp":1654819464000},"page":"1499-1509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Use of Scrambler Therapy in Treating Chronic Pain Syndromes: A Systematic Review"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4300-1711","authenticated-orcid":false,"given":"Jay","family":"Karri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurom.2022.04.045_bib1","first-page":"715","article-title":"The economic costs of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.neurom.2022.04.045_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1186\/1471-2458-13-1229","article-title":"The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care","volume":"13","author":"Breivik","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.neurom.2022.04.045_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1037\/a0035514","article-title":"Interdisciplinary chronic pain management: past, present, and future","volume":"69","author":"Gatchel","year":"2014","journal-title":"Am Psychol"},{"key":"10.1016\/j.neurom.2022.04.045_bib4","doi-asserted-by":"crossref","first-page":"f7656","DOI":"10.1136\/bmj.f7656","article-title":"Neuropathic pain: mechanisms and their clinical implications","volume":"348","author":"Cohen","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.neurom.2022.04.045_bib5","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(21)00794-7","article-title":"Neuromodulation for chronic pain","volume":"397","author":"Knotkova","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neurom.2022.04.045_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11916-016-0590-8","article-title":"Review of recent advances in peripheral nerve stimulation (PNS)","volume":"20","author":"Chakravarthy","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.neurom.2022.04.045_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1163\/156856900750233785","article-title":"\u201cScrambler therapy\u201d: a new option in neuropathic pain treatment?","volume":"12","author":"Serafini","year":"2000","journal-title":"Pain Clin"},{"key":"10.1016\/j.neurom.2022.04.045_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/1534735419845143","article-title":"Inside the scrambler therapy, a noninvasive treatment of chronic neuropathic and cancer pain: from the gate control theory to the active principle of information","volume":"18","author":"Marineo","year":"2019","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.neurom.2022.04.045_bib11","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"621","article-title":"Assessing risk of bias in a non-randomized study","author":"Sterne","year":"2019"},{"key":"10.1016\/j.neurom.2022.04.045_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.neurom.2022.04.045_bib13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jpainsymman.2020.11.025","article-title":"Randomized trial of scrambler therapy for chemotherapy-induced peripheral neuropathy: crossover analysis","volume":"61","author":"Childs","year":"2021","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.neurom.2022.04.045_bib14","first-page":"349","article-title":"Evidence for the efficacy of scrambler therapy for cancer pain: a systematic review","volume":"23","author":"Kashyap","year":"2020","journal-title":"Pain Physician"},{"key":"10.1016\/j.neurom.2022.04.045_bib15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00520-019-04881-3","article-title":"Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial","volume":"28","author":"Loprinzi","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.neurom.2022.04.045_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpainsymman.2011.03.015","article-title":"Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial","volume":"43","author":"Marineo","year":"2012","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.neurom.2022.04.045_bib17","doi-asserted-by":"crossref","first-page":"e1900","DOI":"10.1212\/WNL.0000000000009370","article-title":"Scrambler therapy improves pain in neuromyelitis optica: a randomized controlled trial","volume":"94","author":"Mealy","year":"2020","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1016\/j.neurom.2022.04.045_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/milmed\/usz253","article-title":"Scrambler therapy treatment: the importance of examining clinically meaningful improvements in chronic pain and quality of life","volume":"185","author":"Nayback-Beebe","year":"2020","journal-title":"Mil Med"},{"key":"10.1016\/j.neurom.2022.04.045_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0825859719827589","article-title":"A\u00a0pilot randomized sham-controlled trial of MC5-A scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy (CIPN)","volume":"35","author":"Smith","year":"2020","journal-title":"J\u00a0Palliat Care"},{"key":"10.1016\/j.neurom.2022.04.045_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/nur.21632","article-title":"Decreased low back pain intensity and differential gene expression following Calmare\u00ae: results from a double-blinded randomized sham-controlled study","volume":"38","author":"Starkweather","year":"2015","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.neurom.2022.04.045_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/15360288.2013.847519","article-title":"A\u00a0trial of scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy","volume":"27","author":"Coyne","year":"2013","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.neurom.2022.04.045_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/0973-1075.197948","article-title":"Impact of scrambler therapy on pain management and quality of life in cancer patients: a study of twenty cases","volume":"23","author":"Kashyap","year":"2017","journal-title":"Indian J Palliat Care"},{"key":"10.1016\/j.neurom.2022.04.045_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejon.2015.12.001","article-title":"An exploratory study on the effectiveness of \u201cCalmare therapy\u201d in patients with cancer-related neuropathic pain: a pilot study","volume":"21","author":"Lee","year":"2016","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.neurom.2022.04.045_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0531-5131(03)00661-7","article-title":"Artificial neurons in oncological pain: the potential of scrambler therapy to modify a biological information","volume":"1255","author":"Marineo","year":"2003","journal-title":"Int Congr S"},{"key":"10.1016\/j.neurom.2022.04.045_bib25","doi-asserted-by":"crossref","first-page":"10148","DOI":"10.1038\/s41598-021-89667-6","article-title":"Differential response to scrambler therapy by neuropathic pain phenotypes","volume":"11","author":"Min","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurom.2022.04.045_bib26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00520-014-2424-8","article-title":"Pilot evaluation of scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy","volume":"23","author":"Pachman","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.neurom.2022.04.045_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013895","article-title":"Scrambler therapy: what\u2019s new after 15 years? The results from 219 patients treated for chronic pain","volume":"98","author":"Ricci","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.neurom.2022.04.045_bib28","first-page":"180","article-title":"Scrambler therapy in the management of somatosensory signs and symptoms related to neuropathic pain: an exploratory and prospective analysis","volume":"89","author":"Russo","year":"2018","journal-title":"Acta Biomed"},{"key":"10.1016\/j.neurom.2022.04.045_bib29","first-page":"479","article-title":"Scrambler therapy","volume":"71","author":"Sabato","year":"2005","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.neurom.2022.04.045_bib30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1049909113494002","article-title":"Treatment of postherpetic pain with scrambler therapy, a patient-specific neurocutaneous electrical stimulation device","volume":"35","author":"Smith","year":"2018","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.neurom.2022.04.045_bib31","first-page":"149","article-title":"Chronic pain treatment and scrambler therapy: a multicenter retrospective analysis","volume":"86","author":"Compagnone","year":"2015","journal-title":"Acta Biomed"},{"key":"10.1016\/j.neurom.2022.04.045_bib32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/AJP.0000000000000155","article-title":"Predictive factors associated with success and failure for Calmare (scrambler) therapy: a multicenter analysis","volume":"31","author":"Moon","year":"2015","journal-title":"Clin J Pain"},{"key":"10.1016\/j.neurom.2022.04.045_bib33","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00520-015-2952-x","article-title":"Pilot evaluation of scrambler therapy for pain induced by bone and visceral metastases and refractory to standard therapies","volume":"24","author":"Notaro","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.neurom.2022.04.045_bib34","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1212\/WNL.0b013e31822cfc59","article-title":"Longitudinal assessment of oxaliplatin-induced neuropathy","volume":"77","author":"Burakgazi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurom.2022.04.045_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0956462416656688","article-title":"Treatment of human immunodeficiency virus-related peripheral neuropathy with scrambler therapy: a case report","volume":"28","author":"Smith","year":"2017","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.neurom.2022.04.045_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2217\/pmt-2019-0065","article-title":"Treatment of D\u00e9jerine-Roussy syndrome pain with scrambler therapy","volume":"10","author":"Christo","year":"2020","journal-title":"Pain Manag"},{"key":"10.1016\/j.neurom.2022.04.045_bib37","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.neurom.2022.04.045_bib38","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: a current review","volume":"81","author":"Staff","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurom.2022.04.045_bib39","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.neurom.2022.04.045_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurom.2022.04.045_bib41","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurom.2022.04.045_bib42","doi-asserted-by":"crossref","first-page":"e1387","DOI":"10.1093\/milmed\/usaa089","article-title":"Inaccuracy in the article \u201cScrambler therapy treatment: the importance of examining clinically meaningful improvements in chronic pain and quality of life\u201d","volume":"185","author":"Marineo","year":"2020","journal-title":"Mil Med"}],"container-title":["Neuromodulation: Technology at the Neural Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109471592200681X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109471592200681X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T14:23:06Z","timestamp":1701786186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109471592200681X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S109471592200681X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurom.2022.04.045","relation":{},"ISSN":["1094-7159"],"issn-type":[{"value":"1094-7159","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Scrambler Therapy in Treating Chronic Pain Syndromes: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Neuromodulation: Technology at the Neural Interface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurom.2022.04.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}